Virtus LifeSci Biotech Clinical Trials ETF - USD Stock

ETF

BBC

US26923G3011

Market Closed - 16:10:00 2026-11-09 EST 5-day change 1st Jan Change
44.99 USD +4.58% Intraday chart for Virtus LifeSci Biotech Clinical Trials ETF - USD +7.68% +16.68%

Main features

US26923G3011Fees 0.65% Dividend Policy Distribution
CurrencyUSDAuM (CAD) 79.83M Replication Method Direct (Physical)
Number of securities110AuM evolution - Date of creation 2014-12-15
e46d3acf5cc1e892530fb154.N1RlzTrHnPVPZ1FNZLVLmtqMd9Skvnq3DCfwzaWQi1Q.ZAMgt1Ct5bcnAxsPEM8eyJzHQJfFkwz_P0O1t9Km_QYEHVKScvTLnHsCBA
Name
Indicative Price
Change
Weight
6.550USD+8.62%1.87%
11.35USD+7.69%1.6%
3.870USD-0.26%1.38%
14.00USD+0.14%1.32%
115.07USD+0.03%1.23%
58.02USD+0.07%1.22%
22.30USD+5.44%1.14%
12.11USD+6.70%1.13%
1.060USD+1.92%1.07%
22.74USD+5.77%1.06%

Easily sort and filter through all available ETFs

Access the ETF Screener
In partnership with
TrackInsight

Investment objective

Asset ClassesStocks
Geographical FocusUnited States
Theme and SectorTomorrow's Treatments
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Date Price Change Volume
26-11-09 US$44.99 +4.58% 8,035
26-11-06 US$43.02 +5.62% 97,144
26-11-05 US$40.73 -6.63% 78,882
26-11-04 US$43.62 +1.89% 221,180
26-11-03 US$42.81 +2.47% 60,886